Suppr超能文献

肝脏疾病中溶酶体的研究(作者译)

[Studies on lysosomes in hepatic disorders (author's transl)].

作者信息

Suzuki S

出版信息

Hokkaido Igaku Zasshi. 1979;54(2):177-90.

PMID:488900
Abstract

Lysosome are subcellular particles in which several acid hydrolases of various specificities are localized. The role of lysosome in cellular physiology and pathology has drawn considerable recent attention by several groups of investigators. The purpose of this study was to investigate the activities of lysosomal enzymes--acid phosphatase, beta-glucuronidase, N-acetyl-beta-glucosaminidase--in hepatic disorders. 1) The serum levels of beta-glucuronidase and N-acetyl-beta-glucosaminidase were significantly elevated in patients with diseases of the hepatobiliary system. 2) N-acetyl-beta-glucosaminidase activity in urine specimens from patients with diseases of the hepatobiliary system was found to be significantly higher than in urine specimens from normal adults. 3) Male albino rats of 150 approximately 200 g body weight were used. CCl4 was injected intraperitoneally (dose 0.1 ml of CCl4 per 100 g body weight twice a week for eight weeks). The free activities of lysosomal enzyme were increased and high free/total activity ratios were found in the liver lysosomal fraction of CCl4 intoxicated rats. The results of these experiment indicated that the membranes of lysosome were more permeable to their enzymes, and the release of these enzymes were found in the experimental fatty liver by CCl4. 4) Corticosteroids and chloroquine stabilized rat liver lysosome in vitro from the labilizing influence of incubation at 37 degrees C. 5) The administration of chloroquine to CCl4 intoxicated rats did not cause any well-expressed stabilization of lysosomes. 6) When alpha-Tocopherol was administrated to CCl4 intoxicated rats, the decrease of bound activity and increase of free activity in lysosomal fraction, and increase of acid hydrolases, GOT and GPT in serum were inhibited.

摘要

溶酶体是亚细胞颗粒,其中定位有多种具有不同特异性的酸性水解酶。溶酶体在细胞生理和病理中的作用最近引起了几组研究人员的相当关注。本研究的目的是调查溶酶体酶——酸性磷酸酶、β-葡萄糖醛酸酶、N-乙酰-β-氨基葡萄糖苷酶——在肝脏疾病中的活性。1)肝胆系统疾病患者血清中β-葡萄糖醛酸酶和N-乙酰-β-氨基葡萄糖苷酶水平显著升高。2)发现肝胆系统疾病患者尿液标本中N-乙酰-β-氨基葡萄糖苷酶活性明显高于正常成年人尿液标本。3)使用体重约150至200克的雄性白化大鼠。腹腔注射四氯化碳(剂量为每100克体重0.1毫升四氯化碳,每周两次,共八周)。四氯化碳中毒大鼠肝脏溶酶体部分的溶酶体酶游离活性增加,且游离/总活性比值较高。这些实验结果表明,溶酶体膜对其酶的通透性更高,并且在四氯化碳诱导的实验性脂肪肝中发现了这些酶的释放。4)皮质类固醇和氯喹在体外可使大鼠肝脏溶酶体免受37℃孵育的不稳定影响。5)给四氯化碳中毒大鼠施用氯喹并未导致溶酶体有任何明显的稳定作用。6)当给四氯化碳中毒大鼠施用α-生育酚时,溶酶体部分结合活性的降低和游离活性的增加以及血清中酸性水解酶、谷草转氨酶和谷丙转氨酶的增加受到抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验